PATENT CLAIM ANALYSIS

Application Number: 16060961
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "099000"]

Abstract:
The present invention is related to a pharmaceutical formulation in the form of a sachet which comprises ascorbic acid and phosphomycine trometamol, to be used in treating urinary system infections caused by pathogens sensitive to phosphomycine. The formulation is characterized in that phosphomycine is enabled to be more efficient in treating urinary system infections depending on the fact that ascorbic acid reduces the pH of urine.

Claim (Index 7):
The pharmaceutical formulation according to  claim 6 , wherein the pharmaceutical formulation comprises 0.5 grams to 2 grams of L-Ascorbic Acid in the unit dosage form.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 94.0
- Lexical Diversity: 1.56818
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15510487', '13933323', '13666697', '15328381', '11636105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7268989627725938
- 35 USC 102 Novelty (BERT): 0.4712324998483128
- Combined Prediction Score: 0.7013323164801657
- Mean Citation Score: 135.79318600000002
- Max Citation Score: 141.96944
- Similarity Product: 103.59792232906342

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test